Product Name
CAS Number
Specification
TP
DMF
Status
Retatrutide
Ribociclib
1211441-98-3
Q3 2025
Q1 2026
Rimegepant
1289023-67-1
Q3 2025
Q1 2026
Ritlecitinib
1792180-81-4
Q3 2025
Q1 2026
Rufinamide
106308-44-5
Q4 2025
Q2 2026
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
SNAC
203787-91-1
Q3 2025
Q4 2025
Scopolamine Hydrobromide
114-49-8
Q3 2025
Q1 2026
Seladelpar
851528-79-5
Q3 2026
Q2 2027
Selumetinib
606143-52-6
Q3 2025
Q1 2026
Setmelanotide Acetate
1504602-49-6
Sitafloxacin Hydrate
163253-35-8
In-house
√
Sugammadex Sodium
343306-79-6
In-house
√
Tafluprost
209860-87-7
In-house
√
Tasimelteon
609799-22-6
In-house
√
Teduglutide
197922-42-2
Tepotinib
1100598-32-0
Q4 2025
Q2 2026
Tezacaftor
1152311-62-0
Q3 2025
Q1 2026
Ticagrelor
274693-27-5
EP, In-house
√
Tirzepatide
2023788-19-2